Tin tức & Cập nhật

COVID-19 vaccines safe, effective in NAFLD patients

02 May 2021

Vaccination against SARS-CoV-2 does not seem to come with significant safety concerns in patients with nonalcoholic fatty liver disease (NAFLD), a recent study has found. At the same time, vaccines can also elicit a robust neutralizing antibody response.

COVID-19 vaccines safe, effective in NAFLD patients

02 May 2021

Golexanolone shows promise in cirrhosis

01 May 2021

In patients with cirrhosis, novel small molecule drug golexanolone is well-tolerated and seems to be effective at improving cognitive performance, a new pilot study has found.

Golexanolone shows promise in cirrhosis

01 May 2021

$Prompt ascitic drain removal averts bacterial peritonitis, AKI in cirrhosis with refractory ascites$

Prompt ascitic drain removal averts bacterial peritonitis, AKI in cirrhosis with refractory ascites

27 Apr 2021 bởi

Ascitic drain removal (ADR) within 24 hours among cirrhosis patients with refractory ascites appears to lower the risk of ascitic drain-related bacterial peritonitis (AdBP) and acute kidney injury (AKI), according to a Singapore study.

Prompt ascitic drain removal averts bacterial peritonitis, AKI in cirrhosis with refractory ascites

27 Apr 2021

BIO89-100 reduces liver fat in NASH

27 Apr 2021 bởi

Weekly (QW) or biweekly (Q2W) treatment with BIO89-100 led to a significantly reduced liver fat and liver fat volume (LFV) in patients with nonalcoholic steatohepatitis (NASH), according to a recent study presented at ENDO 2021.

BIO89-100 reduces liver fat in NASH

27 Apr 2021

NA therapy can be withdrawn in noncirrhotic CHB patients

25 Apr 2021

Termination of nucleos(t)ide analogue (NA) therapy is feasible in noncirrhotic patients negative for the hepatitis B e-antigen (HBeAg), a recent study has found. In particular, those with low baseline HB surface antigen (HBsAg) levels see better outcomes after NA withdrawal.

NA therapy can be withdrawn in noncirrhotic CHB patients

25 Apr 2021

Increased meat intake may up risk of several non-cancerous conditions

22 Apr 2021 bởi

An increasing intake of unprocessed red meat and processed meat may be tied to an elevated risk of multiple medical conditions, according to a recent prospective study from the UK.

Increased meat intake may up risk of several non-cancerous conditions

22 Apr 2021

Uncontrolled diabetes mellitus, old age worsen outcomes in advanced cirrhosis

21 Apr 2021

In patients with advanced cirrhosis, uncontrolled diabetes mellitus appears to increase the risk of infections, a recent study has found. When combined with old age, the conditions also hurt survival outlook.

Uncontrolled diabetes mellitus, old age worsen outcomes in advanced cirrhosis

21 Apr 2021

Diets high in protein, unsaturated fats help suppress liver fat

20 Apr 2021

Replacing total dietary carbohydrates with fats does not affect overall liver fat content, while instead replacing it with proteins seems to reduce liver fat, reports a recent meta-analysis.

Diets high in protein, unsaturated fats help suppress liver fat

20 Apr 2021

Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy

06 Apr 2021

Triple therapy with ursodeoxycholic acid, obeticholic acid, and fibrates leads to normalization of biochemical liver tests and pruritus improvement in patients with difficult‐to‐treat primary biliary cholangitis, as shown in a study.

Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy

06 Apr 2021

NAFLD ups glucose intolerance risk despite normal ALT

02 Apr 2021

Fatty liver disease (FLD) is a risk factor for the onset of impaired fasting glucose (IFG) among nonalcoholic adult, a new study has found.

NAFLD ups glucose intolerance risk despite normal ALT

02 Apr 2021

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

COVID-19 vaccines safe, effective in NAFLD patients

COVID-19 vaccines safe, effective in NAFLD patients

Golexanolone shows promise in cirrhosis

Golexanolone shows promise in cirrhosis

Prompt ascitic drain removal averts bacterial peritonitis, AKI in cirrhosis with refractory ascites

Prompt ascitic drain removal averts bacterial peritonitis, AKI in cirrhosis with refractory ascites

BIO89-100 reduces liver fat in NASH

BIO89-100 reduces liver fat in NASH

NA therapy can be withdrawn in noncirrhotic CHB patients

NA therapy can be withdrawn in noncirrhotic CHB patients

Increased meat intake may up risk of several non-cancerous conditions

Increased meat intake may up risk of several non-cancerous conditions

Uncontrolled diabetes mellitus, old age worsen outcomes in advanced cirrhosis

Uncontrolled diabetes mellitus, old age worsen outcomes in advanced cirrhosis

Diets high in protein, unsaturated fats help suppress liver fat

Diets high in protein, unsaturated fats help suppress liver fat

Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy

Difficult‐to‐treat primary biliary cholangitis responds well to triple therapy

NAFLD ups glucose intolerance risk despite normal ALT

NAFLD ups glucose intolerance risk despite normal ALT